193 related articles for article (PubMed ID: 10566781)
1. Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
Canthaboo C; Xing D; Corbel M
Dev Biol Stand; 1999; 101():95-103. PubMed ID: 10566781
[TBL] [Abstract][Full Text] [Related]
2. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
[TBL] [Abstract][Full Text] [Related]
3. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
Canthaboo C; Xing D; Douglas A; Corbel M
Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
[TBL] [Abstract][Full Text] [Related]
4. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo induction of nitric oxide by murine macrophages stimulated with Bordetella pertussis.
Torre D; Ferrario G; Bonetta G; Perversi L; Speranza F
FEMS Immunol Med Microbiol; 1996 Feb; 13(2):95-9. PubMed ID: 8731016
[TBL] [Abstract][Full Text] [Related]
6. Developments in reduction and replacement of in vivo toxicity and potency tests for pertussis vaccines.
Xing D; Canthaboo C; Douglas-Bardsley A; Yuen CT; Prior S; Liu Y; Corbel M
Dev Biol (Basel); 2002; 111():57-68. PubMed ID: 12678225
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide induction in murine macrophages and spleen cells by whole-cell Bordetella pertussis vaccine.
Xing DK; Canthaboo C; Corbel MJ
Vaccine; 1998 Jan; 16(1):16-23. PubMed ID: 9607004
[TBL] [Abstract][Full Text] [Related]
8. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
[TBL] [Abstract][Full Text] [Related]
9. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunisation of murine neonates using whole cell and acellular Pertussis vaccines.
Hale C; Humphreys IR; Hussell T; Bowe F; Clare S; Pickard D; Preston A; Del Giudice G; Dougan G
Vaccine; 2004 Sep; 22(27-28):3595-602. PubMed ID: 15315838
[TBL] [Abstract][Full Text] [Related]
11. A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity.
Mills KH; Brady M; Ryan E; Mahon BP
Dev Biol Stand; 1998; 95():31-41. PubMed ID: 9855412
[TBL] [Abstract][Full Text] [Related]
12. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
[TBL] [Abstract][Full Text] [Related]
14. Effect of pertussis toxin on the induction of nitric oxide synthesis in murine macrophages and on protection in vivo.
Xing DK; Canthaboo C; Corbel MJ
Vaccine; 2000 Apr; 18(20):2110-9. PubMed ID: 10715525
[TBL] [Abstract][Full Text] [Related]
15. Developments in pertussis vaccines leading to reduction and replacement of in vivo testing.
Redhead K
Dev Biol Stand; 1996; 86():263-70. PubMed ID: 8785955
[TBL] [Abstract][Full Text] [Related]
16. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
Tiukavkina SIu; Moskalenko EP
Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
[TBL] [Abstract][Full Text] [Related]
17. Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays.
Xing D; Markey K; Das RG; Feavers I
Expert Rev Vaccines; 2014 Oct; 13(10):1175-82. PubMed ID: 25182836
[TBL] [Abstract][Full Text] [Related]
18. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
